Stocks · News reference

China's 111 Inc. Gets Buyout Proposal From Co-Founders in Going-Private Push

Sep 17, 2026, 12:14 PMAkanksha Bakshi

111 Inc. (YI) reports Q2 2026 results with widened net loss, a shift to asset-light model, and an unsolicited $4.52/ADS privatization bid.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 17, 2026, 11:11 AMBenzinga Insights
Earnings Scheduled For September 17, 2026
Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its second quarter. • Innate Pharma (NASDAQ:IPHA) is projected to report quarterly loss at $0.16 per share on revenue of $9.10
IPHA UPXI YI
BenzingaSep 17, 2026, 8:27 AMBenzinga Newsdesk
111 Inc.'s Board Receives Going-Private Proposal From Co-Founders And Huadeng Tech BioArray Ventures At $4.52 Per ADS
YI
BenzingaSep 17, 2026, 7:12 AMBenzinga Newsdesk
111 Q2 Adj. EPS $(0.60) Down From $(0.40) YoY, Sales $338.995M Down From $447.507M YoY
111 (NASDAQ:YI) reported quarterly losses of $(0.60) per share. This is a 50 percent decrease over losses of $(0.40) per share from the same period last year. The company reported $338.995 million in sales this
YI